Back to results
US 8,524,673 B2Granted
Pharmaceutical formulation
AssigneeKAI Pharmaceuticals, Inc.
InventorMike Tso-ping Li
Life of this patent
Estimating the term…
Abstract
A pharmaceutical formulation for a PKC modulatory peptide and a transport moiety comprising the aforementioned components and an anti-aggregant.
Claims20
A pharmaceutical formulation, comprising:
- a protein kinase C (PKC) modulatory peptide comprising the amino acid sequence of SEQ ID NO:174 chemically coupled to a transport peptide comprising the amino acid sequence of SEQ ID NO:175;
- and
- a sugar, wherein the sugar and the PKC modulatory peptide are present in a ratio from about 100:1 to about 1:1.
A pharmaceutical formulation, comprising:
- a protein kinase C (PKC) modulatory peptide comprising the amino acid sequence of SEQ ID NO:174 chemically coupled to a transport peptide comprising the amino acid sequence of SEQ ID NO:175;
- and
- a sugar, wherein the sugar is sucrose, and
- wherein the sugar and the PKC modulatory peptide are present in a ratio from about 100:1 to about 1:1.
1 more element
A pharmaceutical formulation, comprising:
- a protein kinase C (PKC) modulatory peptide comprising the amino acid sequence of SEQ ID NO:174 chemically coupled to a transport peptide comprising the amino acid sequence of SEQ ID NO:175;
- and
- a sugar, wherein the sugar is fructose, and
- wherein the sugar and the PKC modulatory peptide are present in a ratio from about 100:1 to about 1:1.
1 more element
Dependencies are inferred from the claim text.